AF
ADCT icon

Allworth Financial’s ADC Therapeutics ADCT Stock Holding History

Allworth Financial’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112 Sell
104
-13
-11% -$38 ﹤0.01% 5017
2026
Q1 		$439 Buy
117
+28
+31% +$110 ﹤0.01% 4757
2025
Q4 		$315 Buy
89
+84
+1,680% +$341 ﹤0.01% 4629
2025
Q3 		$20 Buy
+5
New +$16 ﹤0.01% 4827

Other funds holding ADCT

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Allworth Financial's ADCT Position: Q2 2026 in Review

Allworth Financial reduced its ADC Therapeutics (ADCT) stake by 11% in Q2 2026, selling an estimated $38 and leaving 104 shares worth $112. The position accounts for ﹤0.01% of the portfolio, ranked #5017.

Allworth Financial first reported a position in ADCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $439 in Q1 2026. 114 funds tracked by Wall St. Rank hold ADCT as of Q2 2026.

  • Allworth Financial held 104 shares of ADC Therapeutics worth $112 as of Q2 2026.
  • Allworth Financial sold 13 ADC Therapeutics shares in Q2 2026, an estimated $38.
  • ADC Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #5017 holding.
  • Allworth Financial first reported a position in ADC Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Allworth Financial's ADC Therapeutics position peaked at $439 in Q1 2026.
  • 114 funds tracked by Wall St. Rank held ADC Therapeutics as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.